INVO Fertility (NASDAQ:IVF) reported quarterly losses of $(3.38) per share which missed the analyst consensus estimate of $(1.25) by 170.4 percent. This is a 99.78 percent increase over losses of $(1.50 thousand) per share from the same period last year. The company reported quarterly sales of $2.015 million which beat the analyst consensus estimate of $1.980 million by 1.77 percent. This is a 23.09 percent increase over sales of $1.637 million the same period last year.